2-(2-Mercapto-6-oxo-1,6-dihydropyrimidin-4-yl)-N-methylacetamide

Catalog No. :
ACWMAO834
CAS No. :
1105191-77-2
Molecular Formula :
C7H9N3O2S
Molecular Weight :
199.24

IUPAC Name:2-(2-mercapto-6-oxo-1,6-dihydropyrimidin-4-yl)-N-methylacetamide

2-(2-Mercapto-6-oxo-1,6-dihydropyrimidin-4-yl)-N-methylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$125.00Login to see priceIn stockInquiry
250mg95%$221.00Login to see priceIn stockInquiry
1g95%$671.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Mercapto-6-oxo-1,6-dihydropyrimidin-4-yl)-N-methylacetamide
IUPAC Name2-(2-mercapto-6-oxo-1,6-dihydropyrimidin-4-yl)-N-methylacetamide
Molecular FormulaC7H9N3O2S
Molecular Weight199.24
SMILESO=C(NC)CC(N=C(S)N1)=CC1=O
InChI KeyPUEFXXZLURMQOT-UHFFFAOYSA-N
Synonym2-(2-mercapto-6-oxo-1,6-dihydropyrimidin-4-yl)-N-methylacetamide;4-Pyrimidineacetamide, 1,2,3,6-tetrahydro-N-methyl-6-oxo-2-thioxo-
CAS No.1105191-77-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWMAO834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWMAO834 route product structure diagram
    ACWMAO8341105191-77-2 In Stock
Inquiry

2. ACWMAO834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWMAO834 route product structure diagram
    ACWMAO8341105191-77-2 In Stock
Inquiry

Comments (0)